$10.68
-0.24 (-2.20%)
Open$11.00
Previous Close$10.92
Day High$11.99
Day Low$10.40
52W High$21.41
52W Low$6.26
Volume—
Avg Volume44.4K
Market Cap67.96M
P/E Ratio—
EPS$-3.47
SectorBiotechnology
Analyst Ratings
Strong Sell
6 analysts
Price Target
+124.2% upside
Current
$10.68
$10.68
Target
$23.94
$23.94
$16.43
$23.94 avg
$27.23
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 8.74M | 7.84M | 7.34M |
| Net Income | -2,031,310 | -1,359,886 | -1,470,733 |
| Profit Margin | -23.2% | -17.3% | -20.0% |
| EBITDA | -2,389,064 | -2,398,436 | -1,921,173 |
| Free Cash Flow | -1,186,852 | -1,098,506 | -895,782 |
| Rev Growth | +14.6% | -0.2% | +5.0% |
| Debt/Equity | 0.28 | 0.25 | 0.24 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $214.98 | -1.15% | 166.6 | 397.77B |
| AMGN | Amgen Inc | $353.28 | +0.41% | 24.7 | 190.40B |
| GILD | Gilead Sciences Inc | $140.30 | +0.67% | 19.6 | 166.66B |
| VRTX | Vertex Pharmaceuticals Inc | $447.26 | +0.16% | 29.1 | 114.87B |
| REGN | Regeneron Pharmaceuticals | $777.25 | +0.60% | 17.9 | 80.50B |
| ALNY | Alnylam Pharmaceuticals Inc | $328.73 | -0.65% | 139.7 | 43.84B |